Skip to main content
logo
Terumo Corporation (TRUMY)
OTCMKTS · Delayed Price · Currency is USD
16.15
-0.29 (-1.76%)
Jul 18, 2025, 3:51 PM EDT

Revenue by Product

Fiscal year is April - March.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212012 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2012 - 2020
Cardiac and Vascular Company
624.36B
Log In
Log In
Log In
Log In
Upgrade
Cardiac and Vascular Company Growth
12.35%
Log In
Log In
Log In
Log In
Upgrade
Medical Care Solutions Company
211.24B
Log In
Log In
Log In
Log In
Upgrade
Medical Care Solutions Company Growth
6.92%
Log In
Log In
Log In
Log In
Upgrade
Blood and Cell Technologies Company
200.28B
Log In
Log In
Log In
Log In
Upgrade
Blood and Cell Technologies Company Growth
18.98%
Log In
Log In
Log In
Log In
Upgrade
Other
1.00M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Adjustments from
298.00M
Log In
Log In
Log In
Log In
Upgrade
Adjustments from Growth
20.16%
Log In
Log In
Log In
Log In
Upgrade
Other
1.00M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212012 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2012 - 2020
Other
3.00M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Americas
395.65B
Log In
Log In
Log In
Log In
Upgrade
Americas Growth
20.63%
Log In
Log In
Log In
Log In
Upgrade
Europe
218.29B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
13.99%
Log In
Log In
Log In
Log In
Upgrade
China
84.97B
Log In
Log In
Log In
Log In
Upgrade
China Growth
7.00%
Log In
Log In
Log In
Log In
Upgrade
Asia and Others
120.05B
Log In
Log In
Log In
Log In
Upgrade
Asia and Others Growth
7.34%
Log In
Log In
Log In
Log In
Upgrade
Japan
217.21B
Log In
Log In
Log In
Log In
Upgrade
Japan Growth
2.88%
Log In
Log In
Log In
Log In
Upgrade
Other
3.00M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Other

Fiscal year is April - March.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212012 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2012 - 2020
Cardiac and Vascular Company Adjusted Operating Profit
154.68B
Log In
Log In
Log In
Log In
Upgrade
Cardiac and Vascular Company Adjusted Operating Profit Growth
15.38%
Log In
Log In
Log In
Log In
Upgrade
Medical Care Solutions Company Adjusted Operating Profit
22.99B
Log In
Log In
Log In
Log In
Upgrade
Medical Care Solutions Company Adjusted Operating Profit Growth
-0.53%
Log In
Log In
Log In
Log In
Upgrade
Blood and Cell Technologies Company Adjusted Operating Profit
26.48B
Log In
Log In
Log In
Log In
Upgrade
Blood and Cell Technologies Company Adjusted Operating Profit Growth
164.44%
Log In
Log In
Log In
Log In
Upgrade
Adjustments from Adjusted Operating Profit
-712.00M
Log In
Log In
Log In
Log In
Upgrade
Adjustments from Adjusted Operating Profit Growth
171.81%
Log In
Log In
Log In
Log In
Upgrade
Cardiac and Vascular Company Production Result
620.90B
Log In
Log In
Log In
Log In
Upgrade
Cardiac and Vascular Company Production Result Growth
-
Log In
Log In
Log In
Log In
Upgrade
Medical Care Solutions Company Production Result
197.08B
Log In
Log In
Log In
Log In
Upgrade
Medical Care Solutions Company Production Result Growth
-
Log In
Log In
Log In
Log In
Upgrade
Blood and Cell Technologies Company Production Result
205.67B
Log In
Log In
Log In
Log In
Upgrade
Blood and Cell Technologies Company Production Result Growth
-
Log In
Log In
Log In
Log In
Upgrade